Beta-actin Monoclonal Antibody (Ascites) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Other Accession | Q969F1, NP_612417.1 |
---|
Target/Specificity | The synthetic peptide sequence used to generate the antibody AM1021a was selected from the Ascites region of human Beta-actin Monoclonal. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
---|---|
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
beta-Actin is one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, and integrity. This actin is a major constituent of the contractile apparatus and one of the two nonmuscle cytoskeletal actins.
References
Villebeck,L., Biochemistry 46 (44), 12639-12647 (2007)Avizienyte,E., Exp. Cell Res. 313 (15), 3175-3188 (2007)Bouldin,A.A., Muscle Nerve 35 (2), 254-258 (2007)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.